Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Cefotetan for Prophylaxis in Elective Colorectal Surgery
NCT00090272Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2002
- Primary completion
- Mar 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ertapenem in surgical site infection (SSI), sponsored by Merck & Co.. Started Apr 2002; status: completed.
02
Drugs
ertapenem
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT00090272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090272.